| MR编号 | HU/H/0615/001 |
|---|
| 药品名称 | Cefazolin AptaPharma 1 g Powder for solution for injection/infusion |
|---|
| 活性成分 | |
|---|
| 剂型 | Powder for solution for injection/infusion |
|---|
| 上市许可持有人 | Aptapharma Internacional Ltd.
28 Oktovriou, 261
View Piont Tower
Limassol
3035Cyprus
valentina.antoniou@aptapharma.eu |
|---|
| 参考成员国 - 产品名称 | Hungary (HU) |
|---|
| 互认成员国 - 产品名称 | - Croatia (HR)
Cefazolin AptaPharma 1 g prašak za otopinu za injekciju / infuziju - Austria (AT)
Cefazolin AptaPharma 1 g Pulver zur Herstellung einer Injektions-/Infusionslösung - Poland (PL)
Cefazolin AptaPharma - Bulgaria (BG)
Cefazolin Lemepharma - Czechia (CZ)
Cefazolin Lemepharma - Romania (RO)
Cefazolin LemePharma 1 g pulbere pentru soluție injectabilă/perfuzabilă - Slovakia (SK)
Cefazolin AptaPharma 1 g prášok na injekčný/infúzny roztok - Slovenia (SI)
CEFAZOLIN AptaPharma 1 g prašek za raztopino za injiciranje/infundiranje
|
|---|
| 许可日期 | 2020/12/14 |
|---|
| 最近更新日期 | 2021/10/06 |
|---|
| 药物ATC编码 | | 申请类型 | - TypeLevel1：Known Active Substance
- TypeLevel2：Initial Application
- TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|